Bristol-Myers Squibb Company (BMY)

1,153.91 +37.91 (+3.40%)
Closed MXN Disclaimer

BMY Financial Summary

Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 289 million compared to USD 340 million a year ago. Revenue was USD 11,337 million compared to USD 11,648 million a year ago. Net income was USD 2,262 million compared to USD 1,278 million a year ago. Basic earnings per share from continuing operations was USD 1.08 compared to USD 0.6 a year ago. Diluted earnings per share from continuing operations was USD 1.07 compared to USD 0.59 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
BMY
Gross margin TTM 78.46%
Operating margin TTM 20.8%
Net Profit margin TTM 15.95%
Return on Investment TTM 10.25%
Total Revenue
Net Income
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Revenue 11,337 11,406 11,218 11,887
Gross Profit 8,825 8,886 8,951 9,312
Operating Income 2,506 1,773 2,427 2,822
Net Income 2,262 2,022 1,606 1,421
Clear All
0Selected
Please try another search
BMY
Quick Ratio MRQ 1.04
Current Ratio MRQ 1.42
LT Debt to Equity MRQ 110.27%
Total Debt to Equity MRQ 123.76%
Total Assets
Total Liabilities
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Assets 94,281 96,820 98,196 100,357
Total Liabilities 62,395 65,702 65,462 67,696
Total Equity 31,886 31,118 32,734 32,661
Clear All
0Selected
Please try another search
BMY
Cash Flow/Share TTM 5.81
Revenue/Share TTM 21.8
Operating Cash Flow 15.56%
Cash
Net Change in Cash
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Cash From Operating Activities 2,970 3,306 3,687 2,261
Cash From Investing Activities -210 1,213 -2,081 -289
Cash From Financing Activities -3,050 -3,246 -4,543 -3,520
Net Change in Cash -277 1,368 -3,003 -1,619
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.